Skip to main content
Fig. 2 | Hereditas

Fig. 2

From: Integrated multi-omics analysis and machine learning refine molecular subtypes and clinical outcome for hepatocellular carcinoma

Fig. 2

Molecular characterization of hepatocellular carcinoma subtypes. (A-D). Stroma score, Immune score, ESITIMATE score, and Tumor purity in the two subtypes. (E-H). TIDE score, T-cell dysfunction score, T-cell rejection score and microsatellite instability (MSI) score in the two subtypes. (I-L). Comparisons of the IPS in the two subtypes. (M). The enrichment of two subtypes for different treatment-related signatures. (N). Immune profiles in the TCGA-LIHC cohort. The top annotation of the heatmap shows the immune enrichment score, stromal enrichment score, and DNA methylation of tumor-infiltrating lymphocytes. The top panel shows the expression of canonical immune checkpoint genes, and the bottom panel shows the enrichment levels of 24 TME-related immune cells

Back to article page